Five years after dedicating her life to rescuing stray dogs, a woman faces a crisis when Lacy, a dog she cares for, is diagnosed with a worsening, potentially fatal heart murmur. The new medical treatment developed by PMX, the company founded on the mission to help rescued dogs, could save Lacy but is not yet public. Despite pressure to protect the drug’s value, the company decides to donate beta blockers free to shelters, sparking internal conflict over the financial sacrifice. The episode ends as the woman reveals she built the company for Lacy, hinting at a personal and professional turning point.